Lupin Pharmaceuticals Inc. recalls Ramipril Capsules USP 5 mg
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
- Products
-
- Ramipril Capsules USP 5 mg
- Company
- Lupin Pharmaceuticals Inc.
- Where it was sold
-
Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.
Nationwide
- Units affected
- 146,322 bottles
- About this recall
- Ramipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 count (NDC 68180-590-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India